EDGAR Filing Documents for 0001193125-17-059217

Form 8-K - Current report:

SEC Accession No. 0001193125-17-059217

Filing Date

2017-02-27

Accepted

2017-02-27 17:02:05

Documents

Period of Report

2017-02-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d353878d8k.htm	8-K	29397
2	FORM OF WARRANT	d353878dex41.htm	EX-4.1	103565
3	TERM LOAN AGREEMENT, DATED FEBRUARY 21, 2017	d353878dex101.htm	EX-10.1	859009
4	FORM OF SECURITY AGREEMENT	d353878dex102.htm	EX-10.2	124768
5	PRESS RELEASE	d353878dex991.htm	EX-99.1	14391
	Complete submission text file	0001193125-17-059217.txt		1132622

Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612

Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050

BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)